Page 108 - Early Development News Today

- Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI's AI-drug discovery platform and experimentally validated by AstraZeneca - Announcement represents the

Press release content from Business Wire. The AP news staff was not involved in its creation.

As the year comes to an end, biopharma and life sciences companies are strengthening their leadership teams and boards with the latest round of Movers & Shakers.

Novartis has been busy selling off its stake in Roche but quietly this month also got a little extra from its fellow Swiss native after nabbing Bob Baloh, M.D., Ph.D., to run its growing neuroscience division.

Diabetes is associated with a higher risk for incident Parkinsons disease and with worse motor symptoms, more rapid disease progression, new research suggests.

This story originally appeared in the Washington Post Magazine. It aimed to bring the issue of existential environmental threats, which Napakiak and many

BioSpace Movers & Shakers, Dec. 10 - read this article along with other careers information, tips and advice on BioSpace

DUBLIN--(BUSINESS WIRE)--Dec 9, 2021--

/PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery,...

DUBLIN--(BUSINESS WIRE)--The "Peripheral Nerve Stimulators (PNS) - Medical Devices Pipeline Product Landscape, 2021" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive information about the Peripheral Nerve Stimulators (PNS) pipeline products with comparative analysis of th...